Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer

Nicola Dinapoli, Brunella Barbaro, Roberto Gatta, Giuditta Chiloiro, Calogero Casa, Carlotta Masciocchi*, Andrea Damiani, Luca Boldrini, Maria Antonietta Gambacorta, Michele Dezio, Gian Carlo Mattiucci, Mario Balducci, Johan van Soest, Andre Dekker, Philippe Lambin, Claudio Fiorino, Carla Sini, Francesco De Cobelli, Nadia Di Muzio, Calogero GuminaPaolo Passoni, Riccardo Manfredi, Vincenzo Valentini

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

203 Downloads (Pure)

Abstract

Purpose: The objective of this study is finding an intensity based histogram (IBH) signature to predict pathologic complete response (pCR) probability using only pre-treatment magnetic resonance (MR) and validate it externally in order to create a workflow for the external validation of an MR IBH signature and to apply the model out of the environment where it has been tuned. The impact of pCR and the final predictors on the survival outcome were also evaluated.

Methods and Materials: Three centers using different MR scanners were involved in this retrospective study. The first center recruited 162 patients for model training, and the second and third centers provided 34 plus 25 patients for external validation. Patients provided written consent. Accrual period was from May 2008 to December 2014. After surgery pathologic response was defined. T2-weighted MR scans acquired before chemoradiation therapy (CRT) were used for analysis addressed on primary lesions. Images were pre-processed using Laplacian of Gaussian (LoG) filter with multiple s, and first order intensity histogram-based features (kurtosis, skewness, and entropy) were extracted. Features selection was performed using Mann-Whitney test. Tumor staging (cT, cN) was added to build a logistic regression model and predict pCR. Model performance was evaluated with internal and external validation using area under the curve (AUC) of the receiver operator characteristic (ROC) and calibration with Hosmer-Lemeshow test. The linear cross-correlation matrix (Pearson's coefficient) and the variance inflation factor (VIF) were used to check the correlation and the co-linearity among the final predictors. The amount of the information added through the radiomics features was estimated by using the DeLong's test, and the impact of pCR and the final predictors on survival outcomes were evaluated through the Kaplan-Meier curves by using the log-rank test and the multivariate Cox model.

Results: Candidate-to-analysis features were skewness (s=0.485, P value=. 01) and entropy (s = 0.344, P value

Conclusions: This MR-based, vendor-independent model can be helpful for predicting pCR probability in locally advanced rectal cancer (LARC) patients only using pre-treatment imaging. (C) 2018 Elsevier Inc. All rights reserved.

Original languageEnglish
Pages (from-to)765-774
Number of pages10
JournalInternational Journal of Radiation Oncology Biology Physics
Volume102
Issue number4
DOIs
Publication statusPublished - 15 Nov 2018

Keywords

  • CT TEXTURE ANALYSIS
  • POSTOPERATIVE CHEMORADIOTHERAPY
  • NEOADJUVANT CHEMORADIOTHERAPY
  • TUMOR HETEROGENEITY
  • RADIATION-THERAPY
  • CHEMOTHERAPY
  • BIOMARKER
  • SURVIVAL

Cite this